Your browser doesn't support javascript.
loading
Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data.
Wallace, Daniel J; Atsumi, Tatsuya; Daniels, Mark; Hammer, Anne; Meizlik, Paige; Quasny, Holly; Schwarting, Andreas; Zhang, Fengchun; Roth, David A.
Affiliation
  • Wallace DJ; Division of Rheumatology, Cedars-Sinai, Los Angeles, CA, USA.
  • Atsumi T; 163693Department of Rheumatology, Hokkaido University Hospital, Sapporo, Japan.
  • Daniels M; Global Medical Affairs, GSK, Brentford, Middlesex, UK.
  • Hammer A; Biostatistics, GSK, Collegeville, PA, USA.
  • Meizlik P; Global Safety, GSK, Collegeville, PA, USA.
  • Quasny H; At the time of the study.
  • Schwarting A; Research and Development, GSK, Durham, NC, USA.
  • Zhang F; Division of Rheumatology and Clinical Immunology, 22461University Medical Center, Mainz, Germany.
  • Roth DA; Internal Medicine Department, 34732Peking Union Medical College Hospital, Beijing, China.
Lupus ; 31(13): 1649-1659, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36206400
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Clinical_trials / Guideline Limits: Adult / Humans Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Clinical_trials / Guideline Limits: Adult / Humans Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: